- Home
- KOD vs SNFCA Comparison
KOD vs SNFCA Comparison
Compare KOD & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- SNFCA
- Stock Information
- Founded
- KOD 2009
- SNFCA 1965
- Country
- KOD United States
- SNFCA United States
- Employees
- KOD N/A
- SNFCA N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- SNFCA Finance: Consumer Services
- Sector
- KOD Health Care
- SNFCA Finance
- Exchange
- KOD Nasdaq
- SNFCA Nasdaq
- Market Cap
- KOD 198.4M
- SNFCA 235.5M
- IPO Year
- KOD 2018
- SNFCA N/A
- Fundamental
- Price
- KOD $8.84
- SNFCA $8.87
- Analyst Decision
- KOD Hold
- SNFCA
- Analyst Count
- KOD 3
- SNFCA 0
- Target Price
- KOD $9.00
- SNFCA N/A
- AVG Volume (30 Days)
- KOD 549.8K
- SNFCA 152.1K
- Earning Date
- KOD 08-13-2025
- SNFCA 08-13-2025
- Dividend Yield
- KOD N/A
- SNFCA N/A
- EPS Growth
- KOD N/A
- SNFCA 11.71
- EPS
- KOD N/A
- SNFCA 0.93
- Revenue
- KOD N/A
- SNFCA $336,074,193.00
- Revenue This Year
- KOD N/A
- SNFCA N/A
- Revenue Next Year
- KOD N/A
- SNFCA N/A
- P/E Ratio
- KOD N/A
- SNFCA $9.52
- Revenue Growth
- KOD N/A
- SNFCA 4.96
- 52 Week Low
- KOD $1.92
- SNFCA $7.17
- 52 Week High
- KOD $11.60
- SNFCA $12.94
- Technical
- Relative Strength Index (RSI)
- KOD 84.50
- SNFCA 42.71
- Support Level
- KOD $5.00
- SNFCA $8.66
- Resistance Level
- KOD $5.73
- SNFCA $9.25
- Average True Range (ATR)
- KOD 0.70
- SNFCA 0.33
- MACD
- KOD 0.42
- SNFCA -0.03
- Stochastic Oscillator
- KOD 99.61
- SNFCA 18.76
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About SNFCA Security National Financial Corporation
Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.